Home Cart Sign in  
Chemical Structure| 1630086-20-2 Chemical Structure| 1630086-20-2

Structure of Kira8
CAS No.: 1630086-20-2

Chemical Structure| 1630086-20-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Kira8 is an IRE1α inhibitor that plays an important role in studying stress responses and related diseases, potentially aiding in the treatment of various metabolic and cancer diseases.

Synonyms: AMG-18

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Kira8

CAS No. :1630086-20-2
Formula : C31H29ClN6O3S
M.W : 601.12
SMILES Code : O=S(C1=CC=CC=C1Cl)(NC2=CC=CC3=C2C=CC(C)=C3OC4=C(C5=CC=NC(N[C@@H]6CNCCC6)=N5)C=CC=N4)=O
Synonyms :
AMG-18
MDL No. :MFCD28404657
InChI Key :XMWUCMFVDXDRDE-NRFANRHFSA-N
Pubchem ID :118721244

Safety of Kira8

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
KHM-11 cells 10 μM 24 hours KIRA8 decreased cell viability and increased apoptosis PMC7504392
KMS-12-PE cells 10 μM 24 hours KIRA8 decreased cell viability and increased apoptosis PMC7504392
KMS-11 cells 10 μM 24 hours KIRA8 decreased cell viability and increased apoptosis PMC7504392
IM-9 cells 10 μM 24 hours KIRA8 significantly decreased cell viability and induced apoptosis, along with the induction of CHOP expression PMC7504392

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Non-obese diabetic (NOD) Mice model Intraperitoneal injection 50 mg/kg Once daily for 6 weeks Evaluate the reversal effect of KIRA8 on established diabetes, results showed over 90% diabetes reversal rate in KIRA8-treated group PMC5497784

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.66mL

0.33mL

0.17mL

8.32mL

1.66mL

0.83mL

16.64mL

3.33mL

1.66mL

References

 

Historical Records

Categories